Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2010

Authors

  • Genevieve M Klug Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, The University of Melbourne, Victoria, 3010
  • Alison Boyd Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne, Victoria
  • Amelia McGlade Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne, Victoria
  • Christiane Stehmann Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne, Victoria
  • Colin L Masters Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne, Victoria
  • Steven J Collins Australian National Creutzfeldt-Jakob Disease Registry, Department of Pathology, University of Melbourne, Victoria

DOI:

https://doi.org/10.33321/cdi.2011.35.10

Keywords:

Creutzfeldt-Jakob disease, surveillance, prion disease

Abstract

Since the establishment of the Australian National Creutzfeldt-Jakob disease Registry (ANCJDR) it’s activities have expanded from prospectively investigating additional iatrogenic Creutzfeldt-Jakob disease cases to include: retrospective ascertainment to 1970; provision of expert opinions in the area of infection control management; provide diagnostic testing services for all suspect cases; and maintenance of national and international collaborations in conjunction with routine surveillance responsibilities. An update of the ANCJDR’s surveillance activities and outcomes between 1 April and 31 December 2010 is herein presented, including a summation of a recent publication by the ANCJDR. The shorter reporting period is due to a contractual change with the Department of Health and Ageing in 2010, resulting in the reporting timeframe shifting to align with full calendar years. Commun Dis Intell 2011;35(2):149–153.

Downloads

Download data is not yet available.

References

Allars M. Report of the inquiry into the use of pituitary derived hormones in Australia and Creutzfeldt-Jakob disease. Canberra: Australian Government Publishing Service, 1994.

EUROCJD, European Creutzfeldt-Jakob Disease Surveillance Network: EUROCJD Surveillance Data. Available from: http://www.eurocjd.ed.ac.uk/index.htm

World Health Organization. WHO manual for surveillance of human transmissible spongiform encephalopthies including variant Creutzfeldt-Jakob disease, 2003. Available from: http://whqlibdoc.who.int/publications/2003/9241545887.pdf

Will RG. Prion related disorders. J R Coll Physicians Lond 1999;33(4):311–315.

Klug GM, Boyd A, Lewis V, McGlade A, Stehmann C, et al. Surveillance of Creutzfeldt-Jakob disease in Australia: 2010 update. Commun Dis Intell 2010;32(2):96–101.

Boyd A, Klug GMJ, Schonberger L, McGlade A, Brandel J-P, Masters CL, et al. Iatrogenic Creutzfeldt-Jakob disease in Australian: time to amend infection control measures for pituitary hormone recipients? Med J Aust 2010;193(6):366–369.

Downloads

Published

01/06/11

How to Cite

Klug, Genevieve M, Alison Boyd, Amelia McGlade, Christiane Stehmann, Colin L Masters, and Steven J Collins. 2011. “Surveillance of Creutzfeldt-Jakob Disease in Australia: Update to December 2010”. Communicable Diseases Intelligence 35 (June):149-53. https://doi.org/10.33321/cdi.2011.35.10.

Issue

Vol. 35 (2011)

Section

Annual report

Categories

License

Copyright (c) 2011 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 > >>